Measurable Residual Disease Assessment and Allogeneic Transplantation as Consolidation Therapy in Adult Acute Lymphoblastic Leukemia in Colombia

Detectable minimal residual disease (MRD) after therapy for acute lymphoblastic leukemia (ALL) is the strongest predictor of hematologic relapse. The objective of the study was to assess disease-free survival (DFS) and overall survival (OS) of patients with ALL according with MRD status at the end o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2021-04, Vol.21 (4), p.e365-e372
Hauptverfasser:	Combariza, Juan Felipe, Arango, Marcos, Díaz, Laura, Agudelo, Claudia, Hernandez, Sonia, Madera, Ana María, León, Guillermo, Avila, Vladimir, Bautista, Leonardo, Valdés, Jaime, Orduz, Rocio, Mejía, Fabian, Moreno, Liliana, Ramirez, Carlos
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute lymphoblastic leukemia Adolescent Adult Aged Colombia - epidemiology Consolidation Chemotherapy - methods Disease free survival Female Follow-Up Studies Hematopoietic Stem Cell Transplantation Humans Induction Chemotherapy - methods Male Measurable residual disease Middle Aged Neoplasm Recurrence, Local - epidemiology Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy Prognosis Retrospective Studies Transplantation, Homologous Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!